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ScienceDirectThe transition from 2D to 3D cell culture techniques is an
important step in a trend towards better biomimetic tissue
models. Microfluidics allows spatial control over fluids in
micrometer-sized channels has become a valuable tool to
further increase the physiological relevance of 3D cell culture
by enabling spatially controlled co-cultures, perfusion flow and
spatial control over of signaling gradients. This paper reviews
most important developments in microfluidic 3D culture since
2012. Most efforts were exerted in the field of vasculature, both
as a tissue on its own and as part of cancer models. We
observe that the focus is shifting from tool building to
implementation of specific tissue models. The next big
challenge for the field is the full validation of these models and
subsequently the implementation of these models in drug
development pipelines of the pharmaceutical industry and
ultimately in personalized medicine applications.
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Introduction
Two-dimensional cell culture techniques, in which cells
are grown on a flat substrate such as petri-dishes or
microtiter plates, are still common laboratory practice.
However, over the last two decades, awareness of the
relevance of the cellular micro-environment (e.g. the
extracellular matrix and the interstitial fluid) increased.
This new cell culture paradigm, referred to as 3D cell
culture, is rapidly gaining popularity. For example, em-
bedment of cells in an extracellular matrix is associated
with more relevant physiological behavior, such as wit-
nessed by apical–basal polarization [1], lumen formation
[2], reduced proliferation and increased differentiation [3]
and numerous changes in RNA and protein expressionCurrent Opinion in Biotechnology 2015, 35:118–126 [4]. Furthermore, cells cultured in 3D show important
hallmarks of tissues in vivo, such as for example bile duct
formation in liver spheroids [5] and milk protein secretion
by mammary epithelial cells [4].
The transition from 2D to 3D culture techniques is an
important step in a trend towards ever more physiologically
relevant tissue models. However, 3D culture techniques
typically do not yet capture the multicellular complexity of
tissues, lack vasculature, do not offer precise control over
gradients and undergo medium exchange at discrete time
points instead of in a continuous manner.
Microfluidic techniques allow spatial control over fluids
in micrometer-sized channels that can be explored to
extend the physiological relevance of 3D culture
models. Early examples demonstrate spatial patterning
of adhesion molecules [6] and hydrogels [7,8], which are
still used in microfluidic 3D cell culture. Today, the
three most important drivers for the use of microfluidic
techniques in 3D cell culture are:
(i) The ability of co-culturing cells in a spatially
controlled manner
(ii) Generation of and control over (signaling)
gradients.
(iii) The integration of perfusion/flow.
Mechanobiological aspects, such as active stretch and
tension, is another functional aspect that can be added
using microfabrication techniques. Although interesting,
it has received minor attention in combination with 3D
cell culture, and will therefore not be discussed in detail.
The interested reader is referred to a recent review by
Polacheck et al. [9].
In this review, we discuss the most dominant and impor-
tant recent examples of how microfluidic tools were
applied to improve 3D cell culture models. Efforts over
the last two years will be categorized and discussed in the
context of abovementioned drivers. We particularly em-
phasize the contribution of microfluidics to the unmet
needs in 3D cell culture, as well as the role of these
models in the drug development pipeline. For reviews
regarding manufacturing of microfluidic devices we refer
to other publications [10,11]. We observe that the focus is
shifting from tool building to more in-depth focus on the
development of specific models. The full validation of
these models and the symbiosis with recent develop-
ments in stem cell niches and induced pluripotent stem
cells (iPSc) will determine the trend for the coming years.www.sciencedirect.com
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We inventorized 87 papers that contained the keywords
‘[microfluidic OR microengineered] AND 3D cell culture’
which appeared on PubMed since 2012. The papers were
categorized according to the tissue and organ model
addressed and depicted in Figure 1a. Cancer is a particu-
larly dominant field in microfluidic 3D cell culture, and
therefore depicted separately in Figure 1b.
As is shown in Figure 1a, most tissue modelling efforts
were focused on vascularity, followed by brain and liver
tissue models. The striking dominance of efforts in
vascular modelling might be explained by the fact that
microfluidics is the only platform capable of perfusing
such vessels, thereby inducing the vitally important flow
and accompanying shear stresses. This, in addition to
the co-culture context and relevance of gradients in for
instance angiogenesis assays, makes that vasculature
models benefit most from the added value of microflui-
dics [12]. The attention for brain models fits in a wider
trend towards attention for stem cell-derived neuronal
models for diseases such as Alzheimer and Parkinson.
This follows the more generic increase in popularity of
induced pluripotent stem cell techniques and progress
in controlling the stem cell niche of differentiated
tissues.
Cancer is a complex heterogeneous disease and cancer in
vitro models are driven by the demand for phenotypic
screening models. This fits in a trend towards more
systemic approaches to therapy discovery and selection,
as well as in the trend towards tailoring therapies toFigure 1
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Overview of the modelled organs of 87 articles which combine 3D cell
culture with microfluidics since 2012. (a) The distribution of different
organ and tissue models addressed by microfluidic 3D cell culture.
Vasculature was the most modelled tissue, followed by brain and liver.
(b) The distribution of the recently developed cancer models. Breast
and lung tumor models comprise half of the developed models.
Almost half of the cancer models include vasculature.
www.sciencedirect.com individual patient’s characteristics, so-called personalized
medicine. Breast and lung cancer models comprise half of
the developed cancer models (see Figure 1b), correlating
with their high incidence in humans. Vasculature is
involved in many parts of the metastatic cascade, the
spread of cancer cells. Interestingly, many of the recent
developed microfluidic 3D cancer models include a vas-
cular component, as shown in the subgraph of Figure 1b.
These models include processes such as angiogenesis,
migration and intravastion and extravastion, and will be
discussed later.
Microfluidic tools for spatially controlled cell
culture
Spatial control is at the basis of many principles found in
microfluidic 3D cell culture. It allows patterning of cells
and extracellular microenvironment, to create stratified
(co-)cultures with basal–apical access, gradient formation
and medium perfusion.
In classical culture techniques, the spatial control is
usually achieved by a membrane, such as in Boyden
chambers [13], to support surface-attached cell growth,
and separation of the culture reactor in two compart-
ments. Although typically associated with 2D cell culture,
membranes are also widely used in microfluidic chips
[14]. A recent trend in microfluidic systems is to use
hydrogels to offer cells a more physiologically relevant,
three dimensional matrix [15,16]. Hydrogels enable a
more relevant environment in which cell can cluster
together, without need for surface adhesion. Selective
patterning of hydrogels enables co-culture of cells with-
out the need for artificial membranes.
Spatial control over hydrogels is achieved using guiding
structures such as ridges, pillars or posts [17–19]. Alter-
natively, hydrogels can be molded into the right geometry
[20,21]. Bischel et al. show an interesting technique to
pattern cells inside a hydrogel, requiring just a few
pipetting steps. The hydrogel is introduced into the
microfluidic channel. Due to the fluidic properties and
differences in viscosity and pressure, a liquid can create a
lumen inside the hydrogel. A vessel is formed by intro-
ducing a cell suspension, which adheres to the hydrogel
[22] (see Figure 2a).
In the surge towards high throughput, standardized
microfluidic platforms, Trietsch et al. developed a micro-
fluidic 3D co-culture plate with 96 individually address-
able chambers. In this plate, hydrogels are patterned by
phaseguides. Perfusion flow was maintained by passive
levelling between two reservoirs, thereby eliminating the
need for external pumps. The microfluidic channel
dimensions were optimized to enable screening using a
standard fluorescent microscopy. This was demonstrated
by generating a IC50 curve of the toxicity of Rifampicin to
3D liver spheroids (Figure 2b) [23].Current Opinion in Biotechnology 2015, 35:118–126
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Microfluidic techniques for 3D cell culture. (a) Cell patterning inside a hydrogel, exploiting the microfluidic properties and differences in viscosity
and pressure (see text for more details) [22]. (b) 96 microfluidic culture chambers integrated underneath a microtiter plate. Extracellular matrix
gels are selectively patterned in the chamber by phaseguides to obtain a layered profile [23]. (c) A hanging droplet system developed by Frey
et al. [32]. Since the columns and rows are addressable, flexible co-culture setups are possible. This picture demonstrated the hanging
droplet array in combination with a gradient generator. (d) A whole tissue perfusion system developed by Atac¸ et al. [29] tissues are isolated
and cultured on membrane inserts. Microfluidic channels interconnect the tissue chambers, allowing continuous perfusion and paracrine
cell signaling.Cells can also be spatially controlled without hydrogels,
using microchambers or droplets, in which suspended
cells settle and cluster to form spheroids [24–27]. Wang
et al. show an interesting microfluidic device which cap-
tures colon spheroids using an microfluidic cell strainer.
The captured colon spheroids are then embedded in a
hydrogel to provide an extracellular matrix which is
crucial for spheroid growth [28].
Co-culture
The ability to spatially control cells paves the way for
combining multiple cell types in a way that more faith-
fully represents the organization of tissues and organs.
Using hydrogels, cells can be patterned to mimic the
spatial organization found in vivo, which is useful to
mimic for example the interaction between stromal cells
with various tissues. Furthermore, the formation ofCurrent Opinion in Biotechnology 2015, 35:118–126 monolayers against hydrogels allows the study of
trans-endothelial migration of (cancer) cells. Microflui-
dics can also be used to (co-)culture whole tissues and to
interconnect them through microfluidic channels for
media circulation. For example, Atac¸ et al. show a co-
culture of hair follicles with skin tissue slices in a
microfluidic Boyden chamber-like system (Figure 2c)
[29,30]. Vasculature can be included as well by seeding
endothelial cells inside the interconnecting channels
[31].
A hydrogel-free co-culture environment can be created
using a microfluidic hanging drop system. Frey et al.
demonstrate a continuously perfused array containing
both liver and colorectal cancer (CRC) spheroids. This
was used to study drug metabolism and toxicity: the liver
spheroids metabolize a chemotherapeutic compound,www.sciencedirect.com
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(see Figure 2d) [32].
Gradients
In vivo, soluble (bio)molecular gradients are found in
many different biological phenomena, such as angiogen-
esis, invasion and migration. Microfluidic devices have
been developed to study angiogenesis and (anti)angio-
genic factors [19,22,33,34], as well as tumor invasion
assays [35,36].
Since microfluidics enables spatial control over fluids, the
gradients can be precisely controlled. For example, by
patterning a hydrogel between to fluids, stable and pre-
dictable linear gradients are formed. By altering the
channel geometry and applied flow rates, more complex
gradient patterns are possible [37].
Han et al. studied trans-endothelial migration of
neutrophils under influence of a gradient of two che-
mo-attractants, elegantly demonstrating the power of
compartmentalization, spatial control and gradient for-
mation in microfluidic 3D cell culture. They show that
the neutrophils respond differently to the two different
chemo-attractants and correlate ECM stiffness with mi-
gration speed [38].
To integrate these type of assays into the high through-
put drug-screening pipeline, Trietsch et al. [23] demon-
strate gradient formation within their microfluidic titer
plate format. A double perfusion flow was used to gener-
ate a gradient over a compartmentalized hydrogel (see
Figure 2b). This allows high throughput migration
assays, gradient formation in combination with stratified
co-cultures.
Instead of using soluble molecules, cells can be used to
create gradients as well, resulting in heterogeneous cell
densities within a hydrogel. Mahadik et al. show a micro-
fluidic device which creates opposing gradients of two cell
types [39]. This will be a useful tool to determine for
example the optimal cell ratio of niche cells and stem cells.
Perfusion
Perfusion of 3D cell culture is almost exclusively reserved
for microfluidic techniques, since the compartmentalized
nature of microfluidics allows to perfuse media adjacent
to or through a 3D cell culture. Benefits associated with
perfusion flow include stable nutrient supply, waste me-
tabolites removal and control of oxygen tension. Perfu-
sion is one of the crucial aspects in vasculature, as it
provides shear stress, which affects the cellular morphol-
ogy and gene expression [40,41].
Vasculature
In the context of 3D cell culture, vasculature models
benefit most from the added value of these microfluidicswww.sciencedirect.com tools including spatial control, co-culture, gradients and
perfusion. Vascular models are typically grown by seeding
endothelial cells in or against a hydrogel [19,20,34,
37,42–45]. Zheng et al. created a perfusable vascular
network in microchannels that were molded into collagen
(see Figure 2e) [20]. As a result, endothelial cells are
fully surrounded by a natural collagen matrix. Under
perfusion with whole blood, authors showed that upon
stimulation with phorbol-12-myristate-13-acetate (PMA),
long fibers of Von-Willebrand factor (VWF) are secreted.
Webs of VWF-fibers form at channel intersections, which
were demonstrated to trap platelets more effectively.
Tourovskaia et al. used a similar approach for culturing
brain vasculature together with stromal and neuronal
cells in an attempt to create a model for the blood brain
barrier. Pericytes and astrocytes were mixed with col-
lagen that was injected around needles inserted in a
chip. After polymerization, the needles were removed
leaving a lumen that was subsequently seeded with
brain endothelial cells [44], thereby creating a co-
culture of the key cell types that play a role in the
blood brain barrier.
Also endothelial–epithelial vessels can be created, as
demonstrated by a kidney-endothelial double tubules.
A collagen microfluidic structure was used to pattern a
tube of Madin-Darby canine kidney (MDCK) cells, next
to a tube of human umbilical vein endothelial cells
(HUVEC) [45]. Huang et al. also show a perfusable,
stratified MDCK co-culture with adipose derived stem
cells [46], which enhanced cilia formation and increased
expression of ion transporters of the MDCK cells.
The predictability of microfluidic flows can be used to
control the interstitial flow in the cellular microenviron-
ment, as demonstrated by Hsiang Hsu et al. They show a
microfluidic device with endothelial cells and fibroblasts
embedded in hydrogel. Medium is perfused through the
gel from small inlets resulting in spatially defined inter-
stitial flow patterns. The interstitial flow provides me-
chanical cues that induce vasculogenesis, resulting in in
vivo like vascular architecture (Figure 3b) [47].
The mechanical cues however can also be transduced by
the microfluidic channel geometry, as suggested by a
study of the response of endothelial cells on various
curvatures [48]. Within a microfluidic device, HUVEC
and brain microvascular endothelial cells (HBMVEC)
were grown around small glass rods with a diameter of
10 mm, mimicking the curvature found in microcapil-
laries. Under continuous flow, HUVECs and brain micro-
vascular endothelial cells (HBMVEC) responded
differently. At high curvature, brain endothelial cells
resist elongation while HUVECs aligned in the flow
direction, suggesting that this phenotype plays a role in
vivo: by minimizing the elongation, the tight junctionCurrent Opinion in Biotechnology 2015, 35:118–126
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Overview of vasculature models. (a) Vasculature in vitro model developed by Zheng et al. [20]. A grid layout is patterned in collagen gel and
HUVECs are seeded inside. The vasculature shows formation of VWF after perfusion with whole blood and stimulation with phorbol-12-myristate-
13-acetate (PMA). (b) A microfluidic device consisting of a culture chamber filled with hydrogel containing endothelial colony forming cell-derived
endothelial cells (ECFC-ECs) and normal human lung fibroblasts (NHLF). Media is perfused through the gel from small inlets resulting in spatially
defined interstitial flow patterns. This provides the cells with mechanical cues, resulting in in vivo like vascular architecture (see image, cells
labeled with CD31 (green) and DAPI (blue)) [47]. (c) A microfluidic in vitro model for extravasation, using a co-culture of HUVEC cells and a breast
cancer cell line. The breast cancer cells inside the lumen (indicated with 3) extravasate through the endothelial barrier (indicated with 2) into the
matrix (indicated with 1) [52]. (d) Microfluidic angiogenesis model, using a two channel design with lumen inside a collagen gel. HUVEC cells are
seeded and form a vessel, which showed migration (C,i) as well as sprouting (C,ii) of the endothelial cells after stimulation with different pro-
angiogenic factors [21].
Current Opinion in Biotechnology 2015, 35:118–126 www.sciencedirect.com
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transport, one of the hallmarks of the blood brain barrier.
Cancer models
The metastatic cascade, the way cancer cells spread, is
closely linked to the vascular system. Many parts within
the metastatic cascade can be studied by co-culturing
perfusable endothelial vessels with cancer cells. Using
microfluidic 3D cell culture, effects such as angiogenesis
[20,22,33], migration [49,50], intravasation [51] and
extravasation [18,19,44,52] have been studied, and will
be discussed in more detail.
Figure 3c illustrates an extravasation setup in which
endothelial cells are seeded against a compartmentalized
hydrogel. After two days, breast cancer cells (MBA-MD-
231) were perfused through the lumen. The breast cancer
cells extravasated into the gel and increased the endo-
thelial permeability [52]. Bersini et al. modified this setup
by seeding human mesenchymal cells (hMSC) into the
gel, to create a more specific niche for the extravasating
cells and show a significant increase in extravasation
compared with the previous setup. Furthermore, the
authors show that a gradient of cytokine CXCL5 show
similar extravasation compared with the hMSC co-cul-
ture. Blocking the CXCL2 receptor, which has a ligand
for CXCL5, reduced extravasation [18].
An important driver in tumor migration is interstitial flow
[53,54]. A microfluidic 3D interstitial flow chamber was
used to study the migration behavior of MDA-MB-231
breast cancer cells and glioma cells [55].
Many publications show gradient formation of angiogenic
factors in combination with perfusable vasculature to
study angiogenesis [19,20,21,33–36]. Nguyen et al.
study invasion and sprouting of HUVECs which are
exposed to a gradient of various cocktails of pro-angio-
genic factors. Interestingly, they found that a gradient of
vascular endothelial growth factor (VEGF) alone was not
sufficient to trigger angiogenesis. It was found that a
gradient of spingosine-1-phosphate (S) triggered single
cell migration and phorbol 12-myristate 13-acetate (P)
triggered collective cell migration (see Figure 3d). Mix-
tures of multiple pro-angiogenic factors triggered multi-
cellular sprouting; a hallmark of angiogenesis in vivo. This
demonstrates the potential for elucidating molecular
mechanism of angiogenesis using microfluidic devices.
Microfluidics and 3D cell culture: from
exploration to validation to implementation
Above examples demonstrate the potential of microflui-
dic techniques to improve the physiological relevance of
3D cell culture models. We discussed functional addi-
tions such as stratified co-cultures, gradient formation,
vessel formation and medium perfusion. In addition to
the physiological relevance, there are incentives such aswww.sciencedirect.com improved reproducibility, cost effectiveness and/or ease
of handling that may drive the implementation of micro-
fluidics. For example, the reduced dimensions offer
advantages such as reduced consumption of expensive
cell material, hydrogels and screening reagents. Well
defined heights of microfluidic channels dramatically
improve imaging quality and speed. Z-stacking with
confocal imaging equipment might for many assays not
be necessary anymore, as co-culture and migration assays
are patterned in the horizontal plane and most cells lie
within the same focal plane. Precise metering of liquids
with microfluidic techniques enables better quantifica-
tion of assays.
A model system is only as good as the cells that are used to
build it. Human cells are a must for enhanced predictive
models. Primary material is physiologically most relevant,
but suffers from complex logistics, batch-to-batch varia-
tion and often limited life span in vitro. Cell lines over-
come these problems, but are not always considered good
representatives for the in vivo situation. iPSc and organoid
techniques have rapidly increased in popularity. Orga-
noids are derived from primary stem cells. Stem cells
expressing the LGR5 receptor have been identified
which have been shown to maintain stemness in vitro
and differentiate into fully functional intestine, stomach
and liver [56–58]. The iPSC techniques allow reprogram-
ming of fibroblasts into stem cells that can be differenti-
ated into various tissues, such as neurons [59],
cardiomyocytes [60] and several blood lineage cells
[61]. Both cell sources allow to recapitulate various inher-
ited diseases in vitro, and to study genotypic differences.
Microfluidic 3D culture models need to be fully validated
before they can be applied by a wide range of users in
academia and pharmaceutical industry. However, vali-
dation is a challenge in its own, and still an issue for many
in vitro models [62]. It is widely expected that 3D
culture models based on human derived cells are better
predictive of clinical outcome than animal tests due to
their human origin. Animal tests are thus not suited as a
reference model for validation. Retrospective validation
based on clinical results for, for example, successful and
failed compounds with regards to toxicology, should be
used as reference points for validation. However, these
data and the relevant biological materials are in many
cases not publicly available. An alternative validation
strategy is to compare biochemical changes between an in
vitro model system and clinical studies, such as for
example gene expression profiles, enzymatic activities
and metabolism. Clinical biomarkers can guide this vali-
dation and improve the comparability between organ
models and the clinical reference point. To identify
and assess such biomarkers, sensitive analytical methods
are needed such as sequencing, microarray and/or mass
spectrometry techniques. A particular challenge here is
the sensitivity of analytical systems as only smallCurrent Opinion in Biotechnology 2015, 35:118–126
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Timeline of breakthrough developments that contributed to microfluidic 3D cell culture. As the microfluidic tools are in place, we are currently at
the validation phase, a bottleneck that needs to be addressed before the field can advance and replace current in vitro models.amounts of medium and cells are available from micro-
fluidic cell cultures. We expect important developments
in the near future in which microfluidics and Organ-on-a-
Chip systems are coupled with mass spectrometry anal-
ysis [63].
In our opinion, the various microfluidic designs of avail-
able model systems are no longer the bottleneck to the
use of microfluidic 3D cell cultures in a wide range of
academic and industrial applications. Although complica-
tions such as material incompatibility to hydrophobic
compounds, as for instance the case for PDMS systems,
still persist and many chips still lack a user-friendly
interfacing [11], others have addressed these issues in a
convincing manner. As microfluidic technology matures,
the focus will shift towards biological development and
validation of physiologically relevant models (Figure 4).
The trend for the coming years will be to use microfluidic
3D cell culture in combination with the recent advances
in stem cell biology, such as iPSC [64] and organoid
technology. This will allow to take into account differ-
ences between patients in various applications: first, novel
diagnostic tests to predict treatment outcome for an
individual patient; second, supporting clinical trial de-
sign; or third, taking the individual differences already
into account during drug discovery and developments,
both in respect to efficacy and toxicity. Thus, ultimately,
we expect that microfluidic humanized 3D cell cultures
will play an important role in the development of person-
alized medicine.Current Opinion in Biotechnology 2015, 35:118–126 Acknowledgements
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